Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)–The World’s First Oral Epothilone Anti-Cancer Drug
The Global Online/Virtual Fitness Market Expected To Reach $250.7 Billion By 2032
Dotmatics Acquires SoftGenetics Expanding Into Clinical and Forensic Genetic Analysis
Sage Growth Partners Recognized as a Top Agency of the Year
Harmar Mobility Announces Launch of UP Stairlift in United States
America’s Best Wings: Everything You Need to Know
REPORTING. Cambodians, Tunisians, Gabonese: these doctors with foreign diplomas who hold radiology at Montauban hospital
Why do we snore? – ladepeche.fr
5 things to know about phlebitis
towards a finally effective repellent?
Lung, brain, breast…: significant new advances in the fight against cancer
SAN FRANCISCO, June 12, 2023 /PRNewswire/ — Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma...